SCHEMBL7898015

SCHEMBL7898015

c1ccc(CCCCNC2CCN(c3ccc(OCc4ccccc4)cc3)CC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.54
KMT2A Q03164 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
BCHE P06276 2/20 0.52
GRIN2B Q13224 8/20 0.51
FOXM1 Q08050 1/20 0.50
SLC2A1 P11166 1/20 0.47
HRH3 Q9Y5N1 2/20 0.46
GRIN1 Q05586 3/20 0.46
SIGMAR1 Q99720 1/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46
LTA4H P09960 1/20 0.45
EPHX2 P34913 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7902701 0.92 FOXM1 (0.53) KDM4EKMT2ASMN1; SMN2BCHEGRIN2B
SCHEMBL7900897 0.85 GRIN2B (0.59) SMN1; SMN2GRIN2BGRIN1SIGMAR1
SCHEMBL7899612 0.83 GRIN2B (0.61) KMT2AGRIN2BGRIN1SIGMAR1SLC6A2
SCHEMBL7899005 0.82 ME3 (0.60) SMN1; SMN2GRIN2BGRIN1SIGMAR1SLC6A2
SCHEMBL5689918 0.81 KDM4E (0.56) KDM4EKMT2ASMN1; SMN2BCHEGRIN2B
SCHEMBL5690423 0.81 KDM4E (0.56) KDM4EKMT2ASMN1; SMN2BCHEGRIN2B
SCHEMBL5689916 0.81 KDM4E (0.56) KDM4EKMT2ASMN1; SMN2BCHEGRIN2B
SCHEMBL7899165 0.80 ME3 (0.58) LTA4HEPHX2
SCHEMBL7891504 0.79 HRH3 (0.47) KDM4EKMT2ASMN1; SMN2BCHESLC2A1
SCHEMBL7891512 0.78 BCHE (0.45) KDM4EKMT2ASMN1; SMN2BCHESLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1141936-C Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system - 2004-03-17 CN disclosed
US-6184236-B1 Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative HOFFMANN-LA ROCHE INC. 2001-02-06 US disclosed
CN-1248439-A Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system HOFFMAN LA ROCHE & CO AKTEINGE (DE) 2000-03-29 CN disclosed
EP-0982026-A2 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers F. HOFFMANN-LA ROCHE AG (CH) 2000-03-01 EP disclosed